Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
VANGUARD GROUP INC SF Stifel Financial Corp 13G/A 10.18% 2y
VANGUARD GROUP INC EXPO Exponent Inc 13G/A 10.46% 2y
VANGUARD GROUP INC SEM Select Medical Holdings Corp 13G/A 10.13% 2y
VANGUARD GROUP INC CRGY Crescent Energy Co 13G/A 10.16% 2y
VANGUARD GROUP INC MGY Magnolia Oil & Gas Corp 13G/A 11.38% 2y
VANGUARD GROUP INC DOW Dow Inc. 13G/A 10.22% 2y
PERCEPTIVE ADVISORS LLC LABP Landos Biopharma, Inc. Common Stock 13D/A 47.7% 2y
Xontogeny, LLC LABP Landos Biopharma, Inc. Common Stock 13D/A 9.9% 2y
SPX Gestao de Recursos Ltda VSTA Vasta Platform Limited Class A Ordinary Shares 13G 7.5% 2y
Walleye Capital LLC PPYA Papaya Growth Opportunity Corp. I Class A Common Stock 13G/A 3.63% 2y
Northern Star II Sponsor LLC NSTB Northern Star Investment Corp. II 13D/A 84% 2y
SCHULER JACK W BDSX Biodesix Inc 13D/A 27.2% 2y
Matthew Strobeck BDSX Biodesix Inc 13D/A 4.98% 2y
Venu Raman Kumar AERT Aeries Technology, Inc. 13D/A 73.8% 2y
Monte M. Brem STEP StepStone Group Inc. 13D/A 48.9% 2y
Fosun International Ltd LANV Lanvin Group Holdings Ltd 13D/A 58.65% 2y
Lawrence T. Kennedy, Jr. BDSX Biodesix Inc 13D/A 18.7% 2y
John Patience BDSX Biodesix Inc 13D/A 6.7% 2y
CVI Investments, Inc. TARA Protara Therapeutics, Inc. 13G 5.3% 2y
Beaver Hollow Wellness, LLC SVT Servotronics, Inc. 13D/A 16.9% 2y
Bhisham Khare AERT Aeries Technology, Inc. 13D/A 4.4% 2y
Gregory George MESO Mesoblast Ltd 13G/A 13.8% 2y
Kimmeridge Energy Management Company, LLC SBOW SilverBow Resources, Inc. 13D/A 12.9% 2y
Gregory Tamkin MOVE Corvex, Inc. 13G/A 7.66% 2y
Avidity Partners Management LP ORKA Oruka Therapeutics, Inc. 13G 6.9% 2y
Mo Chen TSPH TuSimple Holdings Inc. 13D/A 19.1% 2y
James N. Topper ELEV Elevation Oncology, Inc. Common stock 13G 6.1% 2y
Mubadala Investment Co PJSC EDR Endeavor Group Holdings, Inc. 13D 0.7% 2y
Bayer HealthCare LLC BOLD Boundless Bio, Inc. 13G 7.3% 2y
Phoenix Financial Ltd. TEVA Teva Pharmaceutical Industries Ltd 13G/A 4.83% 2y
Phoenix Financial Ltd. WILCF G Willi Food International Ltd 13G/A 4.9% 2y
Phoenix Financial Ltd. MATW Matthews International Corp 13G/A 4.77% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC FOXF Fox Factory Holding Corp 13G/A 10.09% 2y
Konstantakopoulos, Konstantinos SHIP Seanergy Maritime Holdings Corp. 13G/A 4.98% 2y
SG Americas Securities, LLC RYAAY Ryanair Holdings PLC 13G 5.89% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC DAVA Endava plc 13G/A 10.28% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC THO Thor Industries Inc 13G/A 10.01% 2y
COMPASS GROUP LLC VSTA Vasta Platform Limited Class A Ordinary Shares 13G/A 11.9% 2y
JPMORGAN CHASE & CO NSC Norfolk Southern Corp 13G/A 3.6% 2y
JPMORGAN CHASE & CO RYN Rayonier Inc 13G/A 4.4% 2y
JPMORGAN CHASE & CO RVNC Revance Therapeutics, Inc. 13G/A 2.6% 2y
JPMORGAN CHASE & CO III Information Services Group Inc. 13G/A 4% 2y
JPMORGAN CHASE & CO STEP StepStone Group Inc. 13G/A 4.3% 2y
JPMORGAN CHASE & CO GEL Genesis Energy LP 13G/A 4.4% 2y
JPMORGAN CHASE & CO EVH Evolent Health, Inc. 13G/A 4% 2y
JPMORGAN CHASE & CO KIM Kimco Realty Corp 13G/A 4.3% 2y
JPMORGAN CHASE & CO PMVP PMV Pharmaceuticals, Inc. 13G/A 0% 2y
Karpus Management, Inc. AFJK Aimei Health Technology Co., Ltd. 13G 12.19% 2y
Karpus Management, Inc. ESHA ESH Acquisition Corp. 13G/A 4.21% 2y
Karpus Management, Inc. LBBB Lakeshore Acquisition II Corp. Ordinary Shares 13G/A 0% 2y